Compare CCO & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCO | FLGT |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 867.4M |
| IPO Year | 2005 | 2016 |
| Metric | CCO | FLGT |
|---|---|---|
| Price | $2.23 | $26.35 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $2.10 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 2.1M | 198.7K |
| Earning Date | 02-26-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,569,344,000.00 | $315,549,000.00 |
| Revenue This Year | $6.76 | $16.84 |
| Revenue Next Year | $4.42 | $9.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 54.21 | 13.61 |
| 52 Week Low | $0.81 | $14.57 |
| 52 Week High | $2.28 | $31.04 |
| Indicator | CCO | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 59.40 | 39.69 |
| Support Level | $1.95 | $27.49 |
| Resistance Level | $2.17 | $28.19 |
| Average True Range (ATR) | 0.09 | 0.73 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 79.49 | 15.81 |
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.